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Introduction
Studies have estimated that approximately 50% of breast 
cancer incidence can be attributed to known genetic, 
physiologic, or behavioral risk factors [1], with genetic 
risk factors accounting for 5 to 10% of breast cancer cases 
[2]. Established physiological and behavioral risk factors 
for breast cancer include having a ﬁ  rst-degree relative 
with breast cancer, early menarche, late menopause, 
nulli  parity or bearing of ﬁ  rst child at a later age, over-
weight after menopause, certain types of benign breast 
diseases, alcohol consumption, and long-term use of 
meno  pausal estrogen replacement therapy [3]. In addi-
tion to these well-characterized contributors, other 
factors, whose eﬀ  ects have been more diﬃ   cult to evaluate, 
are suspected of conferring increased breast cancer risk. 
Th   ese factors include smoking, certain aspects of 
nutrition (meat and fat consumption), physical activity, 
and psychological stress [4,5].
Th  e possible contribution of psychological stress to 
breast cancer development has been extensively studied. 
Literature on the topic is not only abundant, spanning 
several decades, but is scattered between the ﬁ  elds of 
epidemiology, physiology, and molecular biology. 
Whereas the largest amount of literature focuses on 
using epidemiologic methods to look for a connection 
between exposure to stress and subsequent breast cancer 
diagnosis, this portion of the literature is also the most 
diﬃ   cult to assess. Studies in this area diﬀ  er greatly in 
their ﬁ  ndings, probably due to diﬀ  erences in factors such 
as study design, the eﬀ  ects of confounding, type of stress 
exposure, and timing of stress exposure or stress expo-
sure measurement. On the other hand, animal literature 
on the topic is simpler to interpret, for the most part 
pointing to a connection between physiological stress 
signaling and breast cancer development. Th  is  literature 
is limited, however, by a lack of variability in stress 
exposure parameters and the diﬀ   erences in breast 
physiology and development between mice and humans. 
Finally, molecular studies demonstrate a clear overlap 
between intracellular stress signaling and protumorigenic 
pathways within breast cells, but need to be integrated 
with other stress–breast cancer research in order to 
obtain an unambiguous assessment of the potential 
cause–eﬀ  ect relationship.
In the present review, we provide a comprehensive 
picture of the current state of knowledge in the stress–
breast cancer ﬁ  eld. We shall ﬁ  rst begin with epidemiology 
(which looks at the stress–breast cancer association in 
human populations) as the most directly relevant study 
of the human condition, will then continue with the 
physiological rationale behind a stress–breast cancer 
asso  ciation, will present physiological research in this 
ﬁ   eld (which examines the direct correlation between 
experimentally-induced stress and tumor development in 
animals), and shall end with molecular biology (providing 
the cellular mechanisms through which stress may 
contribute to breast cancer development). We will 
identify the sources of study discrepancy (in the case of 
epidemiology) or the gaps in knowledge (in the case of 
physiology and molecular biology) that should be 
addressed in order to further advance scientiﬁ  c 
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© 2011 BioMed Central Ltdunderstanding, and we shall discuss future research 
directions that would beneﬁ   t from a multidisciplinary 
approach.
Methodology
English-language article and book sources from MedLine, 
PubMed, and PsycINFO were employed in the present 
review. Th  e listed databases were searched for a large 
number of combinations of terms pertaining to the 
various ﬁ  elds referenced, but some general search terms 
included: stress or psychological stress (cross-referenced 
with terms from all ﬁ  elds, such as cancer, breast cancer, 
mammary gland, glucocorticoid receptor (GR), 
hypothalamic–pituitary–adrenal (HPA) axis, animal 
studies, apoptosis, DNA repair, immunity), cortisol, GR, 
HPA axis, mammary gland development, life events, 
animal studies and cancer. No publication date limits 
were set, but the publication dates for the sources 
included range between 1973 and 2010.
Epidemiologic evidence for a stress–breast cancer 
association
Epidemiologic research on this topic concentrates on 
testing for an association between exposure to a stressful 
stimulus and an outcome of breast tumor diagnosis. 
Historically, this was attempted primarily with the use of 
retrospective case–control study designs where incident 
breast cancer cases are usually matched with population-
based or hospital-based controls. Recollection of expo  sure 
to stress was recorded through questionnaires and assessed 
for its association with breast cancer. Inter  pretation of 
these studies, however, was complicated by a number of 
limitations, the most important of which is potential recall 
bias – subjects are more likely to remember stress 
exposure if they have been diagnosed with breast cancer.
More recently, a type of prospective study design has 
been employed in which exposure information is 
obtained prior to knowledge of breast cancer diagnosis 
(limited prospective design). In such studies, subjects 
who have undergone a biopsy for suspected breast 
disease, but have not yet received a diagnosis, are asked 
about their previous exposure to stress. Although the 
goal of this type of study design is to reduce the recall 
bias associated with case–control studies, it has been 
observed that in many cases women are able to correctly 
predict their diagnosis after biopsy [6]. Recall of stressful 
events may thus still be compromised. Consequently, 
there has been a recent shift in the ﬁ  eld towards the 
employment of truly prospective designs. Th  ese  designs 
aim to determine whether exposure information obtained 
at the beginning of the study is associated with increased 
risk of breast cancer determined after a long period of 
follow-up. Results from some large prospective cohorts 
have recently become available.
In this section we aim to present an overview of the 
current state of knowledge by outlining the trends 
demon  strated by the two main meta-analyses on the 
topic of stress and breast cancer in the ﬁ  eld of epidemi-
ology. In addition, with the help of more recently 
published ﬁ   ndings (Table 1), we aim to identify the 
factors that need to be taken into consideration in order 
to deﬁ   nitively establish whether stress plays a role in 
breast cancer etiology.
A meta-analytical review of epidemiologic studies in 
the area of stress and breast cancer incidence was carried 
out by Petticrew and colleagues, with speciﬁ  c testing for 
an association between bereavement and breast cancer, 
and other life events (including total number of life 
events, major life changes, separation, war experiences, 
serious illness, ﬁ  nancial problems, and work problems) 
and breast cancer [7]. Owing to the scope of the literature 
at the time, the analysis was limited to case–control and 
limited prospective designs: 11 studies for bereavement 
and breast cancer (six case–control studies and ﬁ  ve 
limited prospective studies); 15 studies for other life 
events and breast cancer (eight case–control studies and 
seven limited prospective studies). Th  e studies spanned 
the time period between 1966 and 1997. Th  is meta-
analysis demonstrated no association between bereave-
ment and breast cancer (odds ratio (OR) = 1.06, 95% 
conﬁ  dence interval (CI) = 0.95 to 1.18), but a more than 
twofold increase in breast cancer risk was associated with 
other life events (OR = 2.63, 95% CI = 2.34 to 2.96). 
Limiting the analysis to only the highest quality studies 
(ﬁ   ve for other life events) resulted in no apparent 
association (OR = 0.8, 95% CI = 0.61 to 1.06).
A more recent meta-analysis was performed by Duijts 
and colleagues [8]. Twenty-seven studies published 
between 1966 and December 2002 examining the 
relation  ship between stressful life events and breast 
cancer risk were analyzed. Th  e studies encompassed a 
wider variety of research designs and included ten retro-
spective case–control studies, four prospective case–
control studies, nine limited prospective cohort studies, 
and four prospective cohort studies. Th  e ﬁ  ndings con-
cluded that variables signiﬁ  cantly associated with breast 
cancer risk are an increased number of stressful life 
events (OR = 1.77, 95% CI = 1.31 to 2.40), death of a 
signiﬁ  cant other (OR = 1.37, 95% CI = 1.10 to 1.71), and 
death of a relative or friend (OR = 1.35, 95% CI = 1.09 to 
1.68). Interestingly, a disparity in results was found on the 
basis of study design. Prospective studies showed a 
higher summary OR associated with stressful life events 
than retrospective design studies (OR = 2.46, 95% CI = 
0.98 to 6.18 and OR = 1.93, 95% CI = 1.13 to 3.31, 
respectively). Th   is was attributed to the possible presence 
of recall bias in retrospective studies. In addition, studies 
that took into account well-established breast cancer risk 
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Study Study design Sample size Follow-up
Stress-exposure 
measure
Control for 
confounding Results
Kuper and 
colleagues [15]
Prospective 
cohort
36,332 ~13 years Work-related 
stressors
Yes Association found for low job control and high job 
demands (HR = 1.3 (1.0 to 1.7) for both), and job strain 
(HR = 1.4 (1.1 to 1.9))
Nielsen and 
colleagues [16]
Prospective 
cohort
18,932 10 years Work-related 
stressors
Yes No association found for high work pressure, 
infl  uence on job organization, and long working 
hours; association but no dose–response eff  ect found 
for high work tempo (HR 1.25 (1.02 to 1.54))
Schernhammer 
and colleagues 
[17]
Prospective 
cohort
37,562 8 years Work-related 
stressors
Yes No association found for women in passive (RR = 0.90 
(0.76 to 1.06)), active (RR = 0.83 (0.69 to 0.99)) or 
high-strain jobs (RR = 0.87 (0.73 to 1.04))
Kroenke and 
colleagues [18]
Prospective 
cohort
32,826 8 years Caregiving stress Yes No association found for adult care (RR = 1.19 (0.87 to 
1.62)) or child care (RR = 0.87 (0.66 to 1.16))
Nielsen and 
colleagues [19]
Prospective 
cohort
7,018 16 to 
18 years
Total stress at 
baseline
Yes Lower risk associated with high stress at baseline 
(HR = 0.60 (0.37 to 0.97))
Surtees and 
colleagues [20]
Prospective 
cohort
11,467 Median 
9 years
Diffi   culties in 
childhood, self-
perceived stress
Yes No association found for diffi   culties in childhood 
(HR = 1.02 (0.91 to 1.16)), life events within 5 years 
previous to study (HR = 0.99 (0.89 to 1.11)), or 
perceived stress within 10 years previous to study 
(HR = 1.17 (0.84 to 1.64))
Metcalfe and 
colleagues [21]
Prospective 
cohort
991 30 years Daily stress Yes Mild correlation for moderate (HR = 2.16 (1.00 to 4.71)) 
and high (HR = 1.92 (0.81 to 4.55)) daily stress
Helgesson and 
colleagues [11]
Prospective 
cohort
1,462 24 years Self-perceived stress Yes Association found for self-reported stress during the 
5 years prior to baseline (RR = 2.1 (1.2 to 3.7))
Lillberg and 
colleagues [22]
Prospective 
cohort
10,808 14 years Life events Yes Associations found for major life events (HR = 1.35 
(1.09 to 1.67)), divorce/separation (HR = 2.26 (1.25 to 
4.07)), death of a husband (HR = 2.00 (1.03 to 3.88)), 
or death of a close relative or friend (HR = 1.36 (1.00 
to 1.86))
Lambe and 
colleagues [23]
Registry study 27,571 cases, 
141,798 
controls
Loss of a child Yes Association found for loss of a child between the ages 
of 1 and 4 (OR = 2.65 (1.06 to 6.60))
Ollonen and 
colleagues [24]
Limited 
prospective
34 cases, 
81 controls 
(53 with 
benign breast 
disease, 
28 no disease)
Life events Yes Association found for very severe and severe losses 
(P = 0.02) and greater number of moderate or severe 
losses (P = 0.0009)
Michael and 
colleagues [10]
Prospective 
cohort
84,334 ~ 8 years Life events Yes Association found for one life event (HR = 1.12 (1.0 to 
1.25)), no dose-response
Eskelinen and 
Ollonen [28]
Limited 
prospective
34 cases, 81 
controls (53 
with benign 
breast disease, 
28 no disease)
Losses and defi  cit in 
childhood
Yes Association found for defi  cit in childhood (P <0.05) or 
severe defi  cit in childhood (P = 0.02)
Jacobs and 
Bovasso [29]
Prospective 
cohort
1,213 ~ 15 years Life events Yes Association found for maternal death in childhood 
(OR = 2.56 (1.59 to 4.35))
Keinan-Boker 
and colleagues 
[30]
Registry study 37,872 
women
2,670,238 
person-years 
for women
Holocaust exposure No Association found for Holocaust exposure (RR = 2.44 
(1.46 to 4.06) for youngest birth cohort; lower but 
signifi  cant association for other birth cohorts)
Koupil and 
colleagues [31]
Prospective 
cohort
1,429 
women
Not 
estimated
Leningrad siege 
exposure
Some Association found for Leningrad siege exposure and 
breast cancer mortality in women 10 to 18 years old 
at time of exposure (HR = 9.9 (1.1 to 86.5))
Results data presented as value (95% confi  dence interval). HR, hazard ratio; OR, odds ratio; RR, relative risk.
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stress (for example, OR = 2.22, 95% CI = 1.39 to 3.56 for 
stressful life events), whereas studies that did not control 
for such factors did not report an association when 
pooled (for example, OR = 1.04, 95% CI = 0.90 to 1.20 for 
stressful life events).
Th  e diﬀ   erences between the above-described meta-
analytical results reﬂ   ect the wide diversity in ﬁ  ndings 
between studies. Th   ey also, however, highlight the factors 
that may be sources of discrepancies and that need to be 
addressed in future research in order to move this 
research ﬁ   eld forward. Th  ese factors and some other 
possible causes of discordance are the type of study 
design, control for confounding, the timing of stress 
exposure, and the type of stress exposure. Further 
support for the importance of consideration of these 
factors in study design or analysis is lent by investigations 
published following the release of the discussed meta-
analytical reviews.
Study design and control for confounding
Th  e  inﬂ  uence of study design and control for confounding 
on results is quantitatively demonstrated by the diﬀ  er-
ences in ORs observed in the analysis by Duijts and 
colleagues for retrospective studies and prospective 
studies and for studies accounting for confounding versus 
those that do not [8]. Study design and confounding 
probably contributed to the diﬀ  erence in results between 
the two meta-analyses presented. At the time of the 
earlier analysis, fewer prospective studies had been 
published. In addition, the majority of earlier research 
does not account for the eﬀ  ect of confounding factors. 
Several factors – such as diet, exercise, and hormone 
exposure – are associated with both the exposure (stress) 
and the outcome (breast cancer) of interest, and therefore 
need to be considered in this context as potential 
confounders [8-10].
Another important variable to take into account is the 
eﬀ  ect of socioeconomic status on the association of stress 
with breast cancer risk. At this point in time, it is unclear 
whether stress acts as a mediating factor between socio-
economic status and breast cancer, or whether socio-
economic status and stress are independently correlated 
with breast cancer risk. Evidence has been presented for 
both possibilities [11,12]. Th  e analysis of stress–breast 
cancer associations should therefore be carried out in 
both the presence of and the absence of socioeconomic 
status in order to rule out a confounding eﬀ  ect.
Type of stress
Stress can be acute (short-lived) or chronic (repetitive or 
occurring over an extended period of time) [13,14]. Th  ere 
appears to be a tendency towards stronger associations 
being observed in studies looking at certain types of 
stressful life events and breast cancer incidence, com-
pared with those studies examining chronic stress such as 
work-related stress, caregiving stress, or everyday/total 
stress.
Th  e  eﬀ  ect of work-related stress on breast cancer risk 
was assessed in some recent prospective cohort studies. 
In a study by Kuper and colleagues, the eﬀ  ect of job strain 
on breast cancer incidence was examined among 36,332 
Swedish women participating in the Women’s Lifestyle 
and Health Cohort Study, followed for an average of 
13  years [15]. Th  e results showed that both low job 
control and high job demands were associated with 
breast cancer risk among women working full-time, where-
as an even stronger association was observed among 
women exposed to both of these variables (Table  1). 
Th   ese results were contradicted, however, by results from 
nurse cohort studies. In a prospective cohort study in 
which 18,932 women in the Danish Nurse Cohort were 
assessed for the eﬀ  ect of work-related stressors on breast 
cancer [16], high work pressure, inﬂ   uence on job 
organization and long working hours were not associated 
with breast cancer risk. High work tempo/speed showed 
an association with increased risk but no dose–response 
eﬀ   ect. Similarly, the Nurses’ Health Study showed no 
association between high-strain jobs and breast cancer 
risk [17]. Since the above studies employ a similar design, 
the disparity in ﬁ  ndings regarding work stress suggests 
that the relationship of this type of stress to breast cancer 
is diﬃ   cult to assess accurately, and may be aﬀ  ected by the 
speciﬁ  c measurement method of work stress or by some 
of the other sources of study discrepancy discussed.
Caregiving stress was examined in the Nurses’ Health 
Study in a cohort of 32,826 women followed for 8 years. 
No association between caregiving stress and breast 
cancer was observed [18].
Th  e existence of a relationship between everyday/total 
stress and breast cancer risk has also proven diﬃ   cult to 
establish. Participants in the Copenhagen City Heart Study 
who had reported high levels of stress at baseline were 
found to have a lower risk of developing breast cancer [19]. 
A study examining lifetime social adversity within 11,467 
women in the European Prospective Investi  gation into 
Cancer – Norfolk cohort found no association for speciﬁ  c 
measures of social adversity, such as diﬃ   culties reported in 
childhood, and perceived stress within the previous 10 
years [20]. Th   ese results are opposed by the ﬁ  ndings that 
moderate and high daily stress showed a mild correlation 
with higher breast cancer risk in the West of Scotland 
Collaborative Study [21], and that self-reported stress in 
the 5 years preceding the study baseline is associated with 
breast cancer risk [11].
In contrast to the above stress categories, stress 
induced by life events shows a more consistent asso-
ciation with breast cancer risk in prospective studies. For 
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observed in the Finnish Twin Cohort prospective study 
[22]. An associa  tion for life events with breast cancer risk 
was also observed in a recent registry study [23], in a 
limited prospective design study [24], and in the Women’s 
Health Initiative cohort study [10]. Th  e  European 
Prospective Investigation into Cancer – Norfolk study, 
however, found no association for life events within the 5 
years previous to study baseline [20], demonstrating that 
factors other than the type of stress also contribute to 
study discrepancy.
Timing of stress exposure
Variability between studies may also stem from the 
distinctive time windows of relevant exposure to stress 
examined. Th  e latency period between stress exposure 
and breast cancer initiation is unknown. In general, the 
process of breast cancer development is estimated to 
occur over 10 to 20 years [25,26]. In agreement with this, 
a study by Lillberg and colleagues found that breast 
cancer risk is most strongly correlated with life events 
that have occurred within 11 years prior to diagnosis 
[27]. Since the time periods of exposure examined in 
diﬀ  erent studies vary widely, some of the assessed expo-
sures may fall outside the biologically relevant time, thus 
leading to diﬀ  erent study results.
Another time-associated factor that needs to be taken 
into consideration is the possibility that exposure to 
stress at certain periods of development may have a 
stronger impact on breast physiology. Women diagnosed 
with breast cancer were found to be signiﬁ  cantly more 
likely to have undergone stress due to losses or social 
deﬁ  cits in childhood and adolescence, for example [28]. 
Similarly, death of a mother during a girl’s childhood was 
found to be signiﬁ  cantly associated with increased breast 
cancer risk in a prospective cohort in the Baltimore 
Epidemiologic Catchment Area Study [29]. Finally, in a 
registry study and a prospective cohort study looking at 
association of stress caused by exposure to the Holocaust 
or to the siege of Leningrad with breast cancer risk or 
mortality, respectively, stress among women younger 
than 18 years old was found to be associated with the 
highest risk and mortality of breast cancer (although the 
association in the Leningrad study did not reach 
statistical signiﬁ  cance) [30,31]. Th   ese studies also suggest 
that the cancer-causing eﬀ   ects of stress may be fairly 
speciﬁ  c to the breast. In both cases, all types of cancer 
were examined, and breast cancer showed the strongest 
association with stress.
Conclusions from the epidemiologic literature
Epidemiologic evidence in the area of stress and breast 
cancer outlines several trends. Firstly, the eﬀ  ect of stress 
appears to be relatively breast speciﬁ  c, possibly due to 
the biological roles of stress signaling in the mammary 
gland (described in the next section).
Secondly, the type of stress examined aﬀ  ects the study 
results in this area. Th  e stress most strongly associated 
with increased breast cancer risk appears to be stress 
induced by major life events, whereas ﬁ  ndings regarding 
work-related, caregiving, or everyday stress vary con-
siderably. Th  e dependence of results on the stress type 
may stem from variable biological eﬀ  ects associated with 
diﬀ  erent types of stress, an area that needs to be further 
investigated with the help of physiological methods.
Th  e timing of stress exposure also has an eﬀ  ect on 
breast cancer risk, with early life stress exhibiting the 
strongest association with breast cancer.
Finally, a greater number of prospective studies is 
necessary for each subcategory of stress or timing of 
stress exposure in order to more deﬁ  nitively understand 
the stress–breast cancer relationship.
Biological plausibility of a stress–breast cancer 
association
Th  e plausibility of a stress–breast cancer association 
stems from two important physiological roles of the 
stress hormone cortisol. Cortisol plays an essential part 
in mammary gland development and function, which 
may sensitize mammary tissues to modulations in 
cortisol signaling in the presence of stress. It also has an 
impact on certain aspects of estrogen activity in the 
mammary gland, which may initiate protumorigenic 
changes during periods of stress.
The physiological stress response
Stress is deﬁ  ned as ‘an alteration in the body’s hormonal 
and neuronal secretions caused by the central nervous 
system in response to a perceived threat’ [32,33]. Th  e 
long-term response to psychosocial stressors in humans 
consists of activating the HPA axis of hormonal signaling 
[34]. Cortico  tropin-releasing hormone produced in the 
hypothalamus stimulates the release of adrenocortico-
tropic hormone from the anterior pituitary. Adreno-
corticotropin, in turn, signals the adrenal cortex to 
produce the ‘stress hormone’, cortisol. Cortisol generates 
a physical response to the stress signal by binding to its 
cytoplasmic receptor, GR, and promoting protein, lipid, 
and carbo  hydrate catabolism [35,36].
In its ordinary physiological role, cortisol has protective 
eﬀ  ects on the organism by regulating immune function, 
promoting memory of dangerous events, increasing 
blood pressure and heart rate to meet the physical 
demands of a ﬁ  ght or ﬂ  ight response, and making fuel 
available for sustaining increased physical activity [37]. 
Prolonged stress-response conditions similar to those 
stimulated by stressful life events, however, have been 
shown to predispose for illnesses such as hypertension, 
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cancer in laboratory studies [37-39]. Breast cancer 
development has been proposed to be correlated with 
such prolonged stress exposure [39]. As pointed out above, 
this may be a function of the natural role of cortisol in the 
development and activity of the mammary gland.
Role of stress signaling pathways in the mammary gland
Th   e mammary gland begins to form early during embryo-
genesis and continues to develop in deﬁ  ned stages that 
are correlated with sexual development and reproduction 
[40-42]. Laboratory studies have demonstrated that 
cortisol plays a physiological role in the mammary gland 
mainly in the latter part of pregnancy and during 
lactation (Figure 1). At that stage, placental lactogens 
stimulate DNA synthesis in the mammary cells, and 
cortisol induces the formation of the rough endoplasmic 
reticulum, where milk proteins will be synthesized [42]. 
Prolactin release upon birth causes lobular diﬀ  eren-
tiation, and the secretion of early milk proteins such as β-
casein. Cortisol, on the other hand, predominantly 
regulates the expression of late milk proteins, although it 
has also been shown to play an important role in the 
regulation of β-casein expression [43].
Th  ese breast-speciﬁ   c functions of cortisol signaling 
have been conﬁ  rmed by studies in mice defective for the 
intracellular mediator of cortisol, the GR. Th  ese studies 
have demonstrated that GR activity is involved in the 
ductal development of the virgin mammary gland [44], in 
lobuloalveolar mammary gland development during 
pregnancy (via the induction of proliferation) [45], and in 
stimulating milk production during lactation. Owing to 
the natural functions of cortisol in regulating mammary 
gland biology, its misregulation and prolonged presence 
during periods of stress is likely to expose breast cells to 
the activation of downstream biological pathways outside 
their normal context. Studies indicate that stressful life 
events, as well as job stress, produce elevated cortisol 
levels years after the exposure [46-48]. Th  is elevation 
would signiﬁ  cantly prolong the eﬀ  ect of cortisol on the 
mammary gland. In addition, stress causes permanent 
changes in HPA-axis responsiveness [49,50], which may 
compromise the body’s ability to buﬀ   er any negative 
eﬀ  ects of subse  quent stress exposure.
In concordance with directly aﬀ  ecting the molecular 
signaling pathways of mammary cells, cortisol may 
indirectly contribute to breast tumorigenesis by altering 
the generation or activity of estrogen. A large body of 
evidence suggests that estrogen plays a key role in breast 
cancer etiology [51,52]. One important source of estrogen 
in the breast is the conversion of adrogens to estrone in 
stromal cells by the enzyme aromatase [53,54]. Research 
has shown that aromatase activity [55] and mRNA levels 
[56] are increased in stromal areas surrounding mammary 
tumors and that aromatase is able to stimulate the 
proliferation of breast cancer cells in vitro [57]. Cortisol 
has been characterized as an inducer of aromatase 
activity when in the presence of serum [58] or platelet-
derived growth factor [59]. Treatment of stromal breast 
cells with the glucocorticoid inhibitor RU486 results in 
loss of aromatase activation by the aromatase inducer 
dibutyryl-cAMP [60], demonstrating a necessity for 
cortisol participation in this process. Stimulation of breast 
cancer development by prolonged or elevated presence of 
cortisol during periods of stress may there  fore partially 
occur as a result of augmented estrogen production.
Research in our laboratory has also demonstrated a 
functional interaction between cortisol and estrogen 
signaling. We had previously found that cortisol treat-
ment results in downregulation of expression of the gene 
encoding the tumor-suppressor breast cancer suscepti-
bility gene 1 (BRCA1). Th  e  BRCA1 promoter is known to 
contain an estrogen receptor response element and to be 
activated by estrogen activity [61]. Since BRCA1 is 
capable of blocking estrogen-initiated cell proliferation 
and estrogen signaling pathways [62], the upregulation of 
BRCA1 expression by estrogen is thought to represent a 
feedback mechanism by which rapidly proliferating cells 
control their growth [61]. Factors that obstruct this 
mechanism are expected to produce unchecked cell 
proliferation. We have determined that cortisol may act 
as one such factor. Cortisol treatment of breast cells 
resulted in loss of estrogen-induced stimulation of 
BRCA1 expression [63].
Th   e above-described functions of cortisol may 
contribute to breast cancer development in response to 
stress. Th  eir  eﬀ  ect, however, may be dependent on indi-
vidual genetic stress susceptibility. Speciﬁ  c  polymor-
phisms in the GR gene have been shown to play a role in 
an individual’s response to stress. For example, increased 
GR responsiveness to glucocorticoid signaling has been 
indicated for an aspartic acid to serine change in codon 
363 of the GR (N363S), found in 3 to 7% of Caucasians 
[64]. Th  is heightened sensitivity to stress has been 
correlated with a number of cortisol-speciﬁ  c metabolic 
changes [64-68], and is likely to amplify the eﬀ  ect  of 
cortisol signaling on the mammary gland. Importantly, 
such a genetic predisposition to stress-induced breast 
cancer development is supported by the observation that 
a highly polymorphic dinucleotide CA repeat (D5S207), 
suspected to occur in linkage disequilibrium with a 
polymorphism within the GR locus, is associated with an 
increase in breast cancer risk [69].
Physiological studies on stress and breast tumor 
growth
As discussed in the previous section, multiple variables 
may impact the magnitude or measurement of an 
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Page 6 of 15association between exposure to a stressful stimulus and 
breast cancer development. Th  is complexity makes an 
unequivocal relationship between stress and breast 
cancer diﬃ     cult to demonstrate using epidemiologic 
methods. Laboratory investigations can therefore com-
ple ment  epidemiologic ﬁ  ndings by allowing for a measure-
ment of the impact of stress exposure on mammary gland 
physiology in a controlled environment. Such studies 
(summarized in Table 2) have been carried out in animals 
by employing the method of stress induc  tion via social 
isolation. Social isolation and a change in social environ-
ment are methods previously correlated to an increase in 
the release of adrenocorticotropic hormone and cortico-
sterone [70], and to enhanced tumor size [71,72]. Th  e  use 
of these techniques by the studies outlined below has 
allowed for the establishment of a contributing eﬀ  ect of 
stress on breast tumor growth and incidence.
In a study using male mice transplanted with an 
androgen-responsive mammary tumor, Weinberg and 
Emerman showed that socially isolated animals, addi-
tionally exposed to acute daily novelty stress (changes in 
housing conditions), exhibit a marked increase in tumor 
growth as compared with group-housed animals [73]. 
Th  ese results were conﬁ  rmed in a follow-up study, in 
which mammary-tumor-transplanted mice switched 
from group housing to individual housing were found to 
have faster tumor growth rates as compared with mice 
switched from individual housing to group housing [74].
Figure 1. Role of cortisol in mammary gland development. The role of cortisol is shown for the diff  erent post-embryonic developmental 
stages of the mammary gland. Other hormones involved in the diff  erent developmental stages are also listed. Estrogen and progesterone promote 
ductal system proliferation during puberty. However, the DNA binding function of the glucocorticoid receptor also appears to be required. During 
pregnancy, cortisol contributes to lobuloalveolar development of the mammary gland, in conjunction with estrogen and progesterone. Prolactin 
and cortisol prepare the mammary cells for lactation and stimulate milk protein production following parturition. In addition, cortisol contributes to 
the maintenance of lactation by suppressing involution. ER, endoplasmic reticulum.
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shown by Hermes and colleagues to have an eﬀ  ect on 
lifetime risk of mammary tumor incidence [75]. Socially 
isolated female Norway rats followed for spontaneous 
mammary tumor development were found to exhibit a 
relative risk of 3.3 for developing at least one malignant 
tumor as compared with group-housed animals, although 
there was no signiﬁ  cant  diﬀ   erence in the risk of 
developing a palpable tumor mass in general. Th  e  tumor 
burden in isolated rats was also 84 times higher. Similar 
characteristics of tumor development were observed in 
work by Williams and colleagues in socially isolated mice 
[76]. Th  e study demonstrated that tumor incidence and 
tumor size are both increased in isolated mice when 
compared with group-housed controls, and that this is 
correlated with a higher number of poorly diﬀ  erentiated 
adenocarcinomas.
Interestingly, animals exposed to social isolation early 
in life in the study by Hermes and colleagues showed a 
hyperactive response to psychological stressors later in 
life (this was also observed by Williams and colleagues), 
as well as sustained changes in HPA-axis signaling [75]. 
Hyperactivity of the stress response was, in turn, 
correlated with increased tumor burden. It is tempting to 
speculate that this model presents a situation analogous 
to the eﬀ   ect of stressful life events on the risk of 
developing breast cancer later in life. In fact, human 
studies indicate that HPA-axis signaling in response to a 
stressor is permanently altered following adverse life 
events, such as childhood abuse (although the direction 
Table 2. Physiological studies looking at the eff  ect of stress on DNA damage and tumor development
Study  Study focus  Study design  Subjects  Results
Kiecolt-Glaser and   DNA damage  DNA-repair capacity in  Distressed vs. nondistressed  Lower DNA repair capacity in
colleagues [104]    lymphocytes in response to   psychiatric patients  distressed individuals
   X-ray  irradiation   
Glaser and   DNA damage  DNA repair capacity during  Medical students during  Increase in DNA repair capacity
colleagues [105]    period of stress  examination  during period of stress, possibly 
        as initial response to increased 
       DNA  damage
Cohen and   DNA damage  Levels of O6-methylguanine-  Stressed vs. control rats  Levels of DNA repair enzyme
colleagues [106]    methyltransferase following     are reduced in stressed rats
   stress  exposure   
Fischman and   DNA damage  Rate of sister chromatid exchanges  Stressed vs. control rats  Increase in sister chromatid
colleagues [107]    in response to γ-irradiation,     exchanges in stressed rats; 
    mitomycin-C in the presence of     increased susceptibility to
   environmental  stressors    mutagenesis
Sacharczuk and   DNA damage  Rate of DNA mutation occurrence  Stressed vs. control rats  Increased rate of DNA mutation 
colleagues [108]    Oxidative damage    occurrence in stressed rats
Adachi and   DNA damage  Rate of DNA mutation occurrence  Stressed vs. control rats  Increased rate of DNA mutation
colleagues [109]    Oxidative damage    occurrence in stressed rats
Weinberg and   Tumor development  Tumor growth in response to  Socially isolated vs. group-  Increased tumor growth in
Emerman [73]    acute daily novelty stress  housed male mice  socially isolated animals
Grimm and   Tumor development  Tumor growth in response to change  Mice switched from group to  Increased tumor growth rate in
colleagues [74]    in housing conditions  individual housing vs. individual   mice switched from group to
      to group housing  individual housing
Hermes and   Tumor development  Life-time risk of mammary tumor  Socially isolated vs. group-  Increased risk for developing at
colleagues [75]    incidence, tumor growth rate in   housed female rats  least one malignant tumor; 
    response to social isolation    increased tumor growth; 
        hyperactive response to future 
        stressors; sustained changes in 
       HPA-axis  signaling
Williams and   Tumor development  Tumor incidence, tumor size in  Socially isolated vs. group-  Increased tumor incidence; 
colleagues [76]    response to social isolation  housed mice  increased tumor size; higher 
        number of poorly diff  erentiated 
        adenocarcinomas in socially 
        isolated animals; increased 
        HPA-axis reactivity to additional 
        stress; no permanent changes 
        in baseline corticosterone; 
        global changes in gene 
       expression
HPA, hypothalamic–pituitary–adrenal.
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Page 8 of 15of change diﬀ  ers between studies) [49,50,77], and that 
basal cortisol levels may be aﬀ  ected by early and late life 
events [78,79].
One mechanism for these long-term HPA-axis signal-
ing changes has been revealed through recent investi-
gations employing lack of grooming as a stressor. In these 
studies, rat pups prevented from being groomed exhi-
bited a heightened stress response when exposed to 
stressors as adults [80,81]. Th   is augmented response was 
associated with methylation of a far-upstream element in 
the promoter of the GR gene in cells of the hippocampus, 
subsequent low levels of GR gene expression, and long-
term alteration of HPA-axis signaling due to reduced 
sensitivity to negative feedback control by glucocorticoids 
[82,83].
In addition to its eﬀ   ects on GR expression, social 
isolation was demonstrated to result in global changes in 
gene expression, and to cause the activation of certain 
glycolytic and lipogenic metabolic pathways previously 
correlated with tumor development [76]. Th  ese  ﬁ  ndings 
provide some of the possible pathways aﬀ  ected by stress, 
linking physiological and molecular literature on the 
topic of stress and breast cancer.
Future directions in physiological research
Th  e animal studies discussed above for the most part 
demonstrate a connection between stress exposure and 
breast tumor incidence and growth, corroborating the 
ﬁ  ndings of a subset of the epidemiologic literature. Th  is 
ﬁ  eld suﬀ  ers from a limited number of studies, however, 
and needs to be expanded into research directions that 
would strengthen its applicability to human biology. Th  e 
most important step forward would be to extend the use 
of physiological measures of stress to human studies. 
Although, a retrospective epidemiologic design does not 
allow for a measurement of stress signaling parameters at 
the time of stress exposure, certain prospective designs 
may allow for incorporation of physiological stress-
measurement techniques. For example, physio  logical 
measures can be employed in prospective studies of long-
term stress (such as work strain or caregiving) where the 
exposure is ongoing at the time of study initiation, or to 
test for increased cortisol levels in the presence of a 
history of life events. Validated methods for stress quanti-
ﬁ  cation that can be applied include the measurement of 
morning and evening salivary or blood cortisol levels 
[46,84]. Th  e detection of anti-Epstein–Barr virus anti-
bodies in the blood has also been implicated as an 
indirect biological marker of stress [85,86].
An important parallel that emerges between animal 
and human physiology is the speciﬁ  c role of early life 
stress on breast cancer development. Epidemiologic 
studies, however, demonstrate that in addition to the 
timing of stress exposure, the stress–breast cancer 
asso  ciation depends on the type of stress. A limitation of 
the physiological literature is therefore the lack of 
variability in stress measures. Th   e primary type of stress 
employed in animal studies when studying tumor 
development is social isolation. Th  is type of stress has 
been proposed to be representative of chronic stress 
exposures in humans [87]. Th  e correlation between 
species-speciﬁ   c stress signaling responses, however, 
requires validation. Social stress has also been shown to 
aﬀ  ect the development of the mammary gland during 
puberty, and may therefore not be appropriate for usage 
in the study of early life events [88]. In addition, there is a 
need for animal studies repre  sentative of other human 
stressors, such as life events. Th   ese studies would allow 
for the draw of more direct parallels between animal and 
human ﬁ  ndings.
Molecular studies
Th  e contribution of molecular biology to the stress–
breast cancer ﬁ  eld of research is twofold. Firstly, mole-
cular biology contributes to the understanding of stress 
by allowing the elucidation of the intracellular molecular 
changes which occur in response to stress signaling. 
Secondly, by examin  ing whether stress impacts 
tumorigenic pathways within the mammary gland, 
molecular biology tests the bio  logical plausibility of the 
stress–breast cancer association observed in some of the 
epidemiologic literature. Molecular evidence currently 
points to apoptosis modulation  [89], regulation of 
immune function, and changes in DNA repair 
mechanisms as the main biological mechanisms through 
which stress contributes to cancer development.
Stress and apoptosis in the mammary gland
Consistent with its role in stimulating lactation, cortisol 
has been shown to suppress apoptosis and involution in 
the mammary gland [90] and to stimulate prosurvival 
pathways in nonmalignant mammary epithelial cells in 
vitro [91]. Th  ese observations indicate that prolonged 
exposure to stress may facilitate tumor progression by 
suppressing the removal of genetically altered cells. In 
accordance with these genetic instability-inducing 
eﬀ   ects, glucocorticoids have been found to inhibit 
chemotherapy-induced apop  tosis [92] and to stimulate 
invasiveness [93] and adhesion [94]  of human breast 
tumor cells. Furthermore, the GR was found to be 
overexpressed in 94.4% of metaplastic carcinomas and in 
92.3% of malignant phyllode tumors [95], implying a link 
between increased intracellular stress signaling and the 
development of those types of breast malignancies. 
Interestingly, some studies have pointed to an inhibition 
of the growth of certain mammary tumor cell lines in the 
presence of cortisol [96,97], which may indicate tumor-
type speciﬁ  city of the cortisol eﬀ  ect.
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been proposed for the antiapoptotic eﬀ   ect of stress 
signaling in such cells. Th   e GR, however, has been shown 
to be involved in several apoptosis-related pathways in 
general, which have been reviewed previously [98,99]. In 
the mammary gland in particular, glucocorticoids have 
been found to induce both the mRNA levels of the 
activator protein-1 family members c-fos, jun B, and jun 
D, and activator protein-1 DNA binding activity [90]. 
Th   is induction, in turn, leads to the inhibition of activator 
protein-1 target genes and the suppression of apoptosis 
and of mammary gland involution. In malignant 
mammary cells, the synthetic glucocorticoid dexametha-
sone has been found to repress mitogen-activated protein 
kinase-induced apoptosis by upregulating the expression 
of mitogen-activated protein kinase phosphatase-1 [92]. 
Th   e GR has also been shown to signal through the serum 
and glucocorticoid-regulated kinase-1 to decrease the 
proapoptotic activity of Fork  head transcription factor 3a 
in the breast cancer cell line SKBR-3 [100]. Finally, the 
synthetic glucocorticoid dexa  metha  sone has been found 
to inhibit TNFα-induced apoptosis by suppressing the 
degradation of several inhibitors of apoptosis proteins, 
including cIAP1, cIAP2, and XIAP [101].
Stress and immune detection of transformed cells
Stress may also contribute to mammary tumor develop-
ment by aﬀ   ecting immune system function and the 
elimination of transformed mammary cells. Th  e  eﬀ  ect of 
stress signaling on immunity has been extensively studied 
and was recently reviewed by Webster Marketon and 
Glaser [102]. With respect to cancer development, 
cortisol release in response to psychological stress has 
been suggested to produce a shift in the levels of Th  1  and 
Th  2 cytokines towards a Th  2 response, a decline in 
natural killer cell activity, and a decrease in IFNγ 
production, all of which would aﬀ  ect the ability of the 
immune system to detect and respond to the presence of 
tumor cells [103]. Holden and colleagues have also 
suggested a causal immunological model in which a 
stress-related increase in TNFα results in decreased 
activity of tyrosine phos  phatase and in a consequently 
diminished expression of the class-I MHC antigen on the 
surface of malignant cells, allowing transformed cells to 
escape detection by the immune system [38].
Stress and DNA repair capacity
Alternatively, psychological stress has been demonstrated 
to modulate DNA repair capacity and to promote muta-
genesis (Table 2). For example, highly distressed psychi-
atric patients show signiﬁ  cantly lower DNA repair capa-
city following X-ray irradiation then less distressed 
individuals [104]. Also, in peripheral blood lymphocytes 
and in spleens from stressed rats, levels of an important 
DNA repair enzyme, O6-methylguanine-methyltrans-
ferase, are reduced as compared with those obtained 
from control rats [105]. Interestingly, a study of medical 
students during examination stress demonstrated an 
increase in DNA repair capacity during the period of 
stress, which the authors interpreted as an initial cellular 
response to an increase in DNA damage [106]. Such 
promotion of mutagenesis in response to stress has been 
observed in other studies. Rats exposed to environmental 
stressors exhibit a marked increase in the rate of sister 
chromatid exchanges (an event correlated with both 
mutagenesis and an increase in cancer risk) [107], and are 
more susceptible to mutagenesis induced by γ-irradiation 
and mitomycin-C [108]. Similarly, a higher rate of DNA 
mutation occurrence due to oxidative damage is found in 
rats undergoing psychological distress [109].
Some molecular in vitro results have recently become 
available with regard to the involvement of stress signal-
ing in DNA repair. In murine 3T3 cells, cortisol treatment 
was found to increase intracellular DNA damage by 
approximately ﬁ  vefold and to interfere with the repair of 
ultraviolet-induced DNA damage [110]. In addition, a 
gene array experiment demonstrated that cortisol modu-
lates the expression of genes involved in DNA damage 
signaling, including the proto-oncogene Cdc25A (in-
volved in cell cycle delay following DNA damage) and the 
genes coding for the DNA damage sensors Chk1, Rad53 
and Rad9 [110].
Our own studies have shown in mouse mammary cell 
lines that cortisol downregulates the expression of the 
BRCA1 gene [63]. As an important regulator of both 
DNA repair and apoptosis, the expression of this gene is 
critical in the development of breast cancer – demon-
strated by its frequent mutation in familial breast cancers 
[111,112] and its downregulation in many sporadic breast 
tumors [113]. Th  e loss of 50% of BRCA1 function in 
BRCA1 mutation carriers leads to an altered proﬁ  le of 
gene expression, which resembles the genetic proﬁ  le of 
BRCA1-associated hereditary carcinomas [114]. Th  e 
approximately 50% decrease in BRCA1 levels we ob-
served in response to elevated cortisol levels is therefore 
biologically signiﬁ  cant. To date, BRCA1 regulation is the 
only breast-speciﬁ  c DNA repair pathway that has been 
linked to cortisol signaling.
Future directions in molecular research
Many of the molecular systems described need to be 
tested in the context of mammary gland biology in order 
to validate their speciﬁ  c contribution to breast cancer 
development in response to stress. Another future direc-
tion in this ﬁ  eld should be the application of molecular 
tools to other scientiﬁ  c disciplines studying stress and 
breast cancer. Th   is expansion would allow for a demon-
stration of the biological signiﬁ  cance of diﬀ  erent types of 
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or for obtaining a quantitative measure of the eﬀ  ect of 
stress on mammary cells. For example, as previously 
discussed, the seemingly diﬀ  erent epidemiologic eﬀ  ects 
of work strain or life events on breast cancer risk may 
stem from discor  dance in the molecular mechanisms 
involved. Th  is can be tested by looking at changes in 
relevant gene expression (for example, expression of 
apoptotic or DNA repair genes) in response to each type 
of stress. Th  e observed eﬀ  ect of stress timing on breast 
cancer risk can also be explained by studying the eﬀ  ect of 
stress on gene expres  sion at diﬀ   erent stages of 
Figure 2. Mechanisms of stress signaling in breast cells and of stress-induced breast cancer development. (a) Mechanisms of stress 
signaling in breast cells. Stress-induced cortisol (C) binding to the glucocorticoid receptor (GR) causes translocation of the GR to the cell nucleus 
and changes in the expression of apoptotic and DNA repair genes. Some possible protumorigenic mechanisms include loss of GR transactivation at 
the breast cancer susceptibility gene 1 (BRCA1) promoter, stimulation of activator protein (AP)-1 transrepressing activities, activation of serum and 
glucocorticoid-regulated kinase-1 (SGK-1), repression of mitogen-activated protein kinase (MAPK) signaling, suppression of inhibitors of apoptosis 
protein (IAP) degradation, and modulation of the levels of DNA damage sensor and response proteins. Green arrows represent a positive eff  ect, 
red lines represent a negative eff  ect. (b) A model of stress-induced breast cancer development. The cortisol-activated GR stimulates mammary 
gland proliferation during development and represses involution. Prolonged presence of cortisol, such as in periods of stress, leads to an increase 
in both the proproliferative and antiapoptotic eff  ects of the receptor creating transformation-promoting intracellular conditions. FOXO3a, Forkhead 
transcription factor 3a; MKP-1, mitogen-activated protein kinase phosphatase-1.
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on known GR targets or changes in GR gene methylation 
patterns can be used to conﬁ   rm stress exposure 
occurrence in both animal and human studies.
Summary and conclusion
Elucidation of the factors contributing to the incidence of 
breast cancer is of crucial importance for the develop-
ment of therapeutic or preventative strategies targeting 
the disease. Exposure to psychological stress and stress-
related cortisol release have been proposed to be 
associated with increased breast cancer risk. In the 
present review we have provided an overview of the 
current knowledge on stress signaling and breast cancer, 
incorporating ﬁ   ndings from the several disciplines 
involved (a summary model is presented in Figure 2).
Epidemiologic evidence has been diﬃ   cult to interpret 
due to use of diﬀ  erent measures of stress and other study 
methods that lead to inconsistent ﬁ  ndings.  Recent 
reviews have helped to pinpoint the areas of strongest 
association and have demonstrated that ﬁ  ndings depend 
on the type of study design and the method of exposure 
measurement. Th   ese reviews, however, have also demon-
strated a need for more well-devised studies – ideally, 
prospective cohorts that take into account confounding 
factors and focus on speciﬁ  c types and timing of stress 
exposure. Th  e large population-based cohorts currently 
underway are likely to soon generate more deﬁ  nitive 
answers.
Consolidation of knowledge in the area of physiological 
research demonstrates that laboratory studies, in the 
most part, support a stress–breast cancer association. 
Th  is is consistent with ﬁ   ndings from epidemiologic 
studies looking at the eﬀ  ect of life events on breast cancer 
risk. Since epidemiologic evidence is strongest for a 
speciﬁ  c type of stress exposure, a need exists for a varia-
tion in the types of stress methods used in physiologic 
studies.
Molecular work on the eﬀ  ects of stress in breast cells in 
particular is still in its early stages. Some initial eﬀ  orts 
have been applied towards identifying the intracellular 
pathways aﬀ  ected by cortisol. Th  e suppressive eﬀ  ect of 
cortisol on the apoptotic ability and DNA repair capacity 
of cells, as well as its negative eﬀ   ect on immunity, 
suggests that a connection between stress signaling and 
tumor development is biologically plausible. Additional 
research is needed to identify the particular DNA repair 
and apoptosis genes aﬀ  ected by cortisol and to verify 
whether pathways aﬀ  ected in other cell types are also 
targeted by cortisol in breast cells.
Th  e study of stress and mammary gland malignancy 
may be greatly aided by the employment of an inter-
disciplinary approach to research in this ﬁ  eld. As know-
ledge of stress signaling in the breast increases, these new 
ﬁ   ndings can be applied to other research areas. For 
example, assessment of the activity of GR-related genes 
or binding partners could be included in physio  logical 
studies in order to establish a clear path between external 
stress exposure and intracellular eﬀ  ects, or a combination 
of physiological measures of stress, such as salivary 
cortisol levels, with epidemiologic methods could be 
included to provide a more accurate assessment of stress 
exposure at various relevant periods of life. Th  ere is a 
need for under  standing the diﬀ  ering physiological eﬀ  ects 
of types or times of stress exposure. Th  is need can be 
addressed with the use of both physiological methods to 
measure hor  monal eﬀ   ects and molecular methods to 
identify diﬀ  er  ences in gene regulation. Finally, the use of 
molecular measures of stress susceptibility – such as the 
identiﬁ     cation of GR polymorphisms in epidemiologic 
studies – may help to eliminate a potentially important 
source of study discrepancy in that ﬁ  eld.
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